[64/67Cu]-FAP theranostics in combination with immunotherapy in a preclinical model of TNBC

Sridhar S, Tekin V, Hunt A, Lynch SE, Gallegos CA, Carstens JL, Lapi SE, Sorace A.

Open source

DOI
10.21203/rs.3.rs-10790344/v1
Published
2026-09-08
Container
Not recorded
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 39/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21203/rs.3.rs-10790344/v1,
  title = {[64/67Cu]-FAP theranostics in combination with immunotherapy in a preclinical model of TNBC},
  author = {Sridhar S and  Tekin V and  Hunt A and  Lynch SE and  Gallegos CA and  Carstens JL and  Lapi SE and  Sorace A.},
  year = {2026},
  doi = {10.21203/rs.3.rs-10790344/v1},
  url = {https://doi.org/10.21203/rs.3.rs-10790344/v1}
}

RIS

TY  - JOUR
TI  - [64/67Cu]-FAP theranostics in combination with immunotherapy in a preclinical model of TNBC
AU  - Sridhar S
AU  -  Tekin V
AU  -  Hunt A
AU  -  Lynch SE
AU  -  Gallegos CA
AU  -  Carstens JL
AU  -  Lapi SE
AU  -  Sorace A.
PY  - 2026
DO  - 10.21203/rs.3.rs-10790344/v1
UR  - https://doi.org/10.21203/rs.3.rs-10790344/v1
ER  - 

APA

S, S., V, T., A, H., SE, L., CA, G., JL, C., SE, L., & A., S. (2026). [64/67Cu]-FAP theranostics in combination with immunotherapy in a preclinical model of TNBC. https://doi.org/10.21203/rs.3.rs-10790344/v1

Source records